A phase I–II study of epirubicin, 5-fluorouracil, and leucovorin in advanced adenocarcinoma of the stomach
Open Access
- 1 April 1993
- Vol. 71 (7) , 2177-2180
- https://doi.org/10.1002/1097-0142(19930401)71:7<2177::aid-cncr2820710702>3.0.co;2-q
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Subject IndexAnnals of Oncology, 1991
- Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin.Journal of Clinical Oncology, 1989
- Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue.Journal of Clinical Oncology, 1986
- Controlled Phase III Clinical Study of 4-Epi-Doxorubicin + 5-Fluorouracil versus 5-Fluorouracil Alone in Metastatic Gastric and Rectosigmoid CancerOncology, 1986
- Current status of chemotherapy for advanced pancreatic and gastric cancer.Journal of Clinical Oncology, 1985
- Reporting results of cancer treatmentCancer, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958